 | • レポートコード：MRC2-11QY02898 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は細菌性結膜炎薬のグローバル市場について調査・分析したレポートです。種類別（フルオロキノロン、アミノグリコシド、マクロライド、その他）市場規模、用途別（感染性（ウイルス性・細菌性）、アレルギー性、刺激性（化学的））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別細菌性結膜炎薬の競争状況、市場シェア ・世界の細菌性結膜炎薬市場：種類別市場規模 2015年-2020年（フルオロキノロン、アミノグリコシド、マクロライド、その他） ・世界の細菌性結膜炎薬市場：種類別市場規模予測 2021年-2026年（フルオロキノロン、アミノグリコシド、マクロライド、その他） ・世界の細菌性結膜炎薬市場：用途別市場規模 2015年-2020年（感染性（ウイルス性・細菌性）、アレルギー性、刺激性（化学的）） ・世界の細菌性結膜炎薬市場：用途別市場規模予測 2021年-2026年（感染性（ウイルス性・細菌性）、アレルギー性、刺激性（化学的）） ・北米の細菌性結膜炎薬市場分析：米国、カナダ ・ヨーロッパの細菌性結膜炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの細菌性結膜炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の細菌性結膜炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの細菌性結膜炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Santen Pharmaceutical、Perrigo、Merck、Bayer、Akorn ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Conjunctivitis is an inflammation of the conjunctiva – the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis is one of the most commonly observed eye problems across all age groups, generally caused by bacteria such as Staphylococcus aureus, Moraxella lacunata, Haemophilus influenza, and others (e.g. Chlamydia trachomatis, Proteus mirabilis, etc.).
The development of multi-drug resistant variants, which is resulting in the augmented use of drugs, is expected to boost market growth during the forecast period. Microbes such as Streptococcus or Staphylococcus are responsible for bacterial conjunctivitis. These microbes change themselves chemically to develop resistance to the drugs. Since this resistance develops due to the irrational use of antibiotics, it may lead to severe complications in the body of the patients. Patients are thus expected to take up more medications such as corticosteroids and higher doses of antibiotics for the treatment of such diseases. This augmented use of drugs like corticosteroids and antibiotics for the treatment of bacterial conjunctivitis will propel the prospects for growth in this market.
Market Analysis and Insights: Global Bacterial Conjunctivitis Drugs Market
The global Bacterial Conjunctivitis Drugs market size is projected to reach US$ 434 million by 2026, from US$ 452.8 million in 2020, at a CAGR of -3.7%% during 2021-2026.
Global Bacterial Conjunctivitis Drugs Scope and Market Size
Bacterial Conjunctivitis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Conjunctivitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bacterial Conjunctivitis Drugs market is segmented into
Fluoroquinolones
Aminoglycosides
Macrolides
Others
Segment by Application, the Bacterial Conjunctivitis Drugs market is segmented into
Infective (Viral and Bacterial)
Allergic
Irritant (Chemical)
Regional and Country-level Analysis
The Bacterial Conjunctivitis Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bacterial Conjunctivitis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bacterial Conjunctivitis Drugs Market Share Analysis
Bacterial Conjunctivitis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bacterial Conjunctivitis Drugs business, the date to enter into the Bacterial Conjunctivitis Drugs market, Bacterial Conjunctivitis Drugs product introduction, recent developments, etc.
The major vendors covered:
Santen Pharmaceutical
Perrigo
Merck
Bayer
Akorn
…
1 Study Coverage
1.1 Bacterial Conjunctivitis Drugs Product Introduction
1.2 Market Segments
1.3 Key Bacterial Conjunctivitis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bacterial Conjunctivitis Drugs Market Size Growth Rate by Type
1.4.2 Fluoroquinolones
1.4.3 Aminoglycosides
1.4.4 Macrolides
1.4.5 Others
1.5 Market by Application
1.5.1 Global Bacterial Conjunctivitis Drugs Market Size Growth Rate by Application
1.5.2 Infective (Viral and Bacterial)
1.5.3 Allergic
1.5.4 Irritant (Chemical)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bacterial Conjunctivitis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Bacterial Conjunctivitis Drugs Revenue 2015-2026
2.1.2 Global Bacterial Conjunctivitis Drugs Sales 2015-2026
2.2 Global Bacterial Conjunctivitis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bacterial Conjunctivitis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bacterial Conjunctivitis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bacterial Conjunctivitis Drugs Competitor Landscape by Players
3.1 Bacterial Conjunctivitis Drugs Sales by Manufacturers
3.1.1 Bacterial Conjunctivitis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Bacterial Conjunctivitis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Bacterial Conjunctivitis Drugs Revenue by Manufacturers
3.2.1 Bacterial Conjunctivitis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Bacterial Conjunctivitis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bacterial Conjunctivitis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bacterial Conjunctivitis Drugs Revenue in 2019
3.2.5 Global Bacterial Conjunctivitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bacterial Conjunctivitis Drugs Price by Manufacturers
3.4 Bacterial Conjunctivitis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Bacterial Conjunctivitis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bacterial Conjunctivitis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Bacterial Conjunctivitis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bacterial Conjunctivitis Drugs Market Size by Type (2015-2020)
4.1.1 Global Bacterial Conjunctivitis Drugs Sales by Type (2015-2020)
4.1.2 Global Bacterial Conjunctivitis Drugs Revenue by Type (2015-2020)
4.1.3 Bacterial Conjunctivitis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bacterial Conjunctivitis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Bacterial Conjunctivitis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Bacterial Conjunctivitis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Bacterial Conjunctivitis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bacterial Conjunctivitis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bacterial Conjunctivitis Drugs Market Size by Application (2015-2020)
5.1.1 Global Bacterial Conjunctivitis Drugs Sales by Application (2015-2020)
5.1.2 Global Bacterial Conjunctivitis Drugs Revenue by Application (2015-2020)
5.1.3 Bacterial Conjunctivitis Drugs Price by Application (2015-2020)
5.2 Bacterial Conjunctivitis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Bacterial Conjunctivitis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Bacterial Conjunctivitis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Bacterial Conjunctivitis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bacterial Conjunctivitis Drugs by Country
6.1.1 North America Bacterial Conjunctivitis Drugs Sales by Country
6.1.2 North America Bacterial Conjunctivitis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bacterial Conjunctivitis Drugs Market Facts & Figures by Type
6.3 North America Bacterial Conjunctivitis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Bacterial Conjunctivitis Drugs by Country
7.1.1 Europe Bacterial Conjunctivitis Drugs Sales by Country
7.1.2 Europe Bacterial Conjunctivitis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bacterial Conjunctivitis Drugs Market Facts & Figures by Type
7.3 Europe Bacterial Conjunctivitis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bacterial Conjunctivitis Drugs by Region
8.1.1 Asia Pacific Bacterial Conjunctivitis Drugs Sales by Region
8.1.2 Asia Pacific Bacterial Conjunctivitis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bacterial Conjunctivitis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Bacterial Conjunctivitis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bacterial Conjunctivitis Drugs by Country
9.1.1 Latin America Bacterial Conjunctivitis Drugs Sales by Country
9.1.2 Latin America Bacterial Conjunctivitis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bacterial Conjunctivitis Drugs Market Facts & Figures by Type
9.3 Central & South America Bacterial Conjunctivitis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bacterial Conjunctivitis Drugs by Country
10.1.1 Middle East and Africa Bacterial Conjunctivitis Drugs Sales by Country
10.1.2 Middle East and Africa Bacterial Conjunctivitis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bacterial Conjunctivitis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Bacterial Conjunctivitis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Santen Pharmaceutical
11.1.1 Santen Pharmaceutical Corporation Information
11.1.2 Santen Pharmaceutical Description and Business Overview
11.1.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Products Offered
11.1.5 Santen Pharmaceutical Related Developments
11.2 Perrigo
11.2.1 Perrigo Corporation Information
11.2.2 Perrigo Description and Business Overview
11.2.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Perrigo Bacterial Conjunctivitis Drugs Products Offered
11.2.5 Perrigo Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Bacterial Conjunctivitis Drugs Products Offered
11.3.5 Merck Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Bacterial Conjunctivitis Drugs Products Offered
11.4.5 Bayer Related Developments
11.5 Akorn
11.5.1 Akorn Corporation Information
11.5.2 Akorn Description and Business Overview
11.5.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Akorn Bacterial Conjunctivitis Drugs Products Offered
11.5.5 Akorn Related Developments
11.1 Santen Pharmaceutical
11.1.1 Santen Pharmaceutical Corporation Information
11.1.2 Santen Pharmaceutical Description and Business Overview
11.1.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Products Offered
11.1.5 Santen Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bacterial Conjunctivitis Drugs Market Estimates and Projections by Region
12.1.1 Global Bacterial Conjunctivitis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Bacterial Conjunctivitis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Bacterial Conjunctivitis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Bacterial Conjunctivitis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Bacterial Conjunctivitis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Bacterial Conjunctivitis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Bacterial Conjunctivitis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Bacterial Conjunctivitis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Bacterial Conjunctivitis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Bacterial Conjunctivitis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bacterial Conjunctivitis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bacterial Conjunctivitis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bacterial Conjunctivitis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bacterial Conjunctivitis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Bacterial Conjunctivitis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Bacterial Conjunctivitis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Bacterial Conjunctivitis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Bacterial Conjunctivitis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bacterial Conjunctivitis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bacterial Conjunctivitis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bacterial Conjunctivitis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bacterial Conjunctivitis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bacterial Conjunctivitis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bacterial Conjunctivitis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bacterial Conjunctivitis Drugs Market Segments
Table 2. Ranking of Global Top Bacterial Conjunctivitis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bacterial Conjunctivitis Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Fluoroquinolones
Table 5. Major Manufacturers of Aminoglycosides
Table 6. Major Manufacturers of Macrolides
Table 7. Major Manufacturers of Others
Table 8. Global Bacterial Conjunctivitis Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Bacterial Conjunctivitis Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Bacterial Conjunctivitis Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Bacterial Conjunctivitis Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Bacterial Conjunctivitis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Bacterial Conjunctivitis Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Bacterial Conjunctivitis Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Bacterial Conjunctivitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Bacterial Conjunctivitis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Conjunctivitis Drugs as of 2019)
Table 17. Bacterial Conjunctivitis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Bacterial Conjunctivitis Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Bacterial Conjunctivitis Drugs Price (2015-2020) (USD/MT)
Table 20. Bacterial Conjunctivitis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Bacterial Conjunctivitis Drugs Product Type
Table 22. Date of International Manufacturers Enter into Bacterial Conjunctivitis Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Bacterial Conjunctivitis Drugs Sales by Type (2015-2020) (K MT)
Table 25. Global Bacterial Conjunctivitis Drugs Sales Share by Type (2015-2020)
Table 26. Global Bacterial Conjunctivitis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Bacterial Conjunctivitis Drugs Revenue Share by Type (2015-2020)
Table 28. Bacterial Conjunctivitis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Bacterial Conjunctivitis Drugs Sales by Application (2015-2020) (K MT)
Table 30. Global Bacterial Conjunctivitis Drugs Sales Share by Application (2015-2020)
Table 31. North America Bacterial Conjunctivitis Drugs Sales by Country (2015-2020) (K MT)
Table 32. North America Bacterial Conjunctivitis Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Bacterial Conjunctivitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Bacterial Conjunctivitis Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Bacterial Conjunctivitis Drugs Sales by Type (2015-2020) (K MT)
Table 36. North America Bacterial Conjunctivitis Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Bacterial Conjunctivitis Drugs Sales by Application (2015-2020) (K MT)
Table 38. North America Bacterial Conjunctivitis Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Bacterial Conjunctivitis Drugs Sales by Country (2015-2020) (K MT)
Table 40. Europe Bacterial Conjunctivitis Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Bacterial Conjunctivitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Bacterial Conjunctivitis Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Bacterial Conjunctivitis Drugs Sales by Type (2015-2020) (K MT)
Table 44. Europe Bacterial Conjunctivitis Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Bacterial Conjunctivitis Drugs Sales by Application (2015-2020) (K MT)
Table 46. Europe Bacterial Conjunctivitis Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Bacterial Conjunctivitis Drugs Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Bacterial Conjunctivitis Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Bacterial Conjunctivitis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Bacterial Conjunctivitis Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Bacterial Conjunctivitis Drugs Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Bacterial Conjunctivitis Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Bacterial Conjunctivitis Drugs Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Bacterial Conjunctivitis Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Bacterial Conjunctivitis Drugs Sales by Country (2015-2020) (K MT)
Table 56. Latin America Bacterial Conjunctivitis Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Bacterial Conjunctivitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Bacterial Conjunctivitis Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Bacterial Conjunctivitis Drugs Sales by Type (2015-2020) (K MT)
Table 60. Latin America Bacterial Conjunctivitis Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Bacterial Conjunctivitis Drugs Sales by Application (2015-2020) (K MT)
Table 62. Latin America Bacterial Conjunctivitis Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Bacterial Conjunctivitis Drugs Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Bacterial Conjunctivitis Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Bacterial Conjunctivitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Bacterial Conjunctivitis Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Bacterial Conjunctivitis Drugs Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Bacterial Conjunctivitis Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Bacterial Conjunctivitis Drugs Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Bacterial Conjunctivitis Drugs Sales Market Share by Application (2015-2020)
Table 71. Santen Pharmaceutical Corporation Information
Table 72. Santen Pharmaceutical Description and Major Businesses
Table 73. Santen Pharmaceutical Bacterial Conjunctivitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Santen Pharmaceutical Product
Table 75. Santen Pharmaceutical Recent Development
Table 76. Perrigo Corporation Information
Table 77. Perrigo Description and Major Businesses
Table 78. Perrigo Bacterial Conjunctivitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Perrigo Product
Table 80. Perrigo Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Bacterial Conjunctivitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Bayer Corporation Information
Table 87. Bayer Description and Major Businesses
Table 88. Bayer Bacterial Conjunctivitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Bayer Product
Table 90. Bayer Recent Development
Table 91. Akorn Corporation Information
Table 92. Akorn Description and Major Businesses
Table 93. Akorn Bacterial Conjunctivitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Akorn Product
Table 95. Akorn Recent Development
Table 96. Global Bacterial Conjunctivitis Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 97. Global Bacterial Conjunctivitis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Bacterial Conjunctivitis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Bacterial Conjunctivitis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Bacterial Conjunctivitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 101. North America: Bacterial Conjunctivitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Bacterial Conjunctivitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 103. Europe: Bacterial Conjunctivitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Bacterial Conjunctivitis Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 105. Asia Pacific: Bacterial Conjunctivitis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Bacterial Conjunctivitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 107. Latin America: Bacterial Conjunctivitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Bacterial Conjunctivitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 109. Middle East and Africa: Bacterial Conjunctivitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Bacterial Conjunctivitis Drugs Players
Table 114. Bacterial Conjunctivitis Drugs Customers List
Table 115. Bacterial Conjunctivitis Drugs Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Bacterial Conjunctivitis Drugs Product Picture
Figure 2. Global Bacterial Conjunctivitis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Fluoroquinolones Product Picture
Figure 4. Aminoglycosides Product Picture
Figure 5. Macrolides Product Picture
Figure 6. Others Product Picture
Figure 7. Global Bacterial Conjunctivitis Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Infective (Viral and Bacterial)
Figure 9. Allergic
Figure 10. Irritant (Chemical)
Figure 11. Bacterial Conjunctivitis Drugs Report Years Considered
Figure 12. Global Bacterial Conjunctivitis Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Bacterial Conjunctivitis Drugs Sales 2015-2026 (K MT)
Figure 14. Global Bacterial Conjunctivitis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Bacterial Conjunctivitis Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Bacterial Conjunctivitis Drugs Sales Market Share by Region in 2019
Figure 17. Global Bacterial Conjunctivitis Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Bacterial Conjunctivitis Drugs Revenue Market Share by Region in 2019
Figure 19. Global Bacterial Conjunctivitis Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Bacterial Conjunctivitis Drugs Revenue in 2019
Figure 21. Bacterial Conjunctivitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Bacterial Conjunctivitis Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Bacterial Conjunctivitis Drugs Sales Market Share by Type in 2019
Figure 24. Global Bacterial Conjunctivitis Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Bacterial Conjunctivitis Drugs Revenue Market Share by Type in 2019
Figure 26. Global Bacterial Conjunctivitis Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Bacterial Conjunctivitis Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Bacterial Conjunctivitis Drugs Sales Market Share by Application in 2019
Figure 29. Global Bacterial Conjunctivitis Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Bacterial Conjunctivitis Drugs Revenue Market Share by Application in 2019
Figure 31. North America Bacterial Conjunctivitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Bacterial Conjunctivitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Bacterial Conjunctivitis Drugs Sales Market Share by Country in 2019
Figure 34. North America Bacterial Conjunctivitis Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Bacterial Conjunctivitis Drugs Market Share by Type in 2019
Figure 40. North America Bacterial Conjunctivitis Drugs Market Share by Application in 2019
Figure 41. Europe Bacterial Conjunctivitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Bacterial Conjunctivitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Bacterial Conjunctivitis Drugs Sales Market Share by Country in 2019
Figure 44. Europe Bacterial Conjunctivitis Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Bacterial Conjunctivitis Drugs Market Share by Type in 2019
Figure 56. Europe Bacterial Conjunctivitis Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Bacterial Conjunctivitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Bacterial Conjunctivitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Bacterial Conjunctivitis Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Bacterial Conjunctivitis Drugs Revenue Market Share by Region in 2019
Figure 61. China Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Bacterial Conjunctivitis Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Bacterial Conjunctivitis Drugs Market Share by Application in 2019
Figure 85. Latin America Bacterial Conjunctivitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Bacterial Conjunctivitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Bacterial Conjunctivitis Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Bacterial Conjunctivitis Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Bacterial Conjunctivitis Drugs Market Share by Type in 2019
Figure 96. Latin America Bacterial Conjunctivitis Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Bacterial Conjunctivitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Bacterial Conjunctivitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Bacterial Conjunctivitis Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Bacterial Conjunctivitis Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Bacterial Conjunctivitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Bacterial Conjunctivitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Bacterial Conjunctivitis Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Bacterial Conjunctivitis Drugs Market Share by Application in 2019
Figure 109. North America Bacterial Conjunctivitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Bacterial Conjunctivitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Bacterial Conjunctivitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Bacterial Conjunctivitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Bacterial Conjunctivitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Bacterial Conjunctivitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Bacterial Conjunctivitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Bacterial Conjunctivitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Bacterial Conjunctivitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Bacterial Conjunctivitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
細菌性結膜炎治療の世界市場（～2026年） Bacterial conjunctivitis is a serious eye infection caused by several types of bacteria. The aforementioned figures clarify that it is one of the most common eye problems affecting people of all ages across the U.S. Such higher prevalence of the disease definitely prompts at increasing demand for ef…- ウイルス性結膜炎治療薬の世界市場（～2026年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…
- 結膜炎治療薬の世界市場（～2026年） Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in …
- ウイルス性結膜炎パイプライン薬剤の世界市場（～2026年） Market Analysis and Insights: Global Viral Conjunctivitis Pipeline Drugs Market The global Viral Conjunctivitis Pipeline Drugs market size is projected to reach US$ 51 million by 2026, from US$ 36 million in 2020, at a CAGR of 39.5%% during 2021-2026. Global Viral Conjunctivitis Pipeline Drugs Scope…
- 細菌性膣炎薬の世界市場（～2026年） Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis inclu…